HESTER BIOSCIENCES
|
The Current P/E Ratio of HESTER BIOSCIENCES is 14.57.
| Share Price | ₹2,333.5 | Nov 12,2026 |
| Market Cap | ₹1,983.4 Cr | |
| Earnings-TTM | ₹136.1 Cr | TTM-Consolidated Results |
| Price/Earnings | 14.57x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of HESTER BIOSCIENCES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹1,983.4 Cr] as on Nov 12,2026
(/) Earnings [ ₹136.1 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 14.57x ]
Thus, for HESTER BIOSCIENCES , the investors are currently willing to pay 14.57 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of HESTER BIOSCIENCES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of HESTER BIOSCIENCES over the last five years.
Historical PE (Price/Earnings) ratio chart of HESTER BIOSCIENCES
PE Ratio Performance Analysis for HESTER BIOSCIENCES
- HESTER BIOSCIENCES 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 45.60x.
- HESTER BIOSCIENCES 's operated at median p/e ratio of 48.58x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, HESTER BIOSCIENCES 's p/e ratio peaked in Mar2024 at 62.57x.
- HESTER BIOSCIENCES 's p/e ratio hit its five-year low in Mar2026 of 19.31x.
How does HESTER BIOSCIENCES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| HESTER BIOSCIENCES | 136.11 | 14.57 | 1,983.4 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,037.20 | 41.02 | 452,707.0 |
| DIVIS LABORATORIES LTD | 3,363.00 | 90.38 | 303,962.0 |
| TORRENT PHARMACEUTICALS LTD | 2,099.00 | 85.51 | 179,494.0 |
| CIPLA LTD | 2,868.29 | 39.71 | 113,912.0 |
| DR REDDYS LABORATORIES LTD | 2,759.70 | 41.95 | 115,769.0 |
| MANKIND PHARMA LTD | 2,249.69 | 48.38 | 108,837.0 |
| LUPIN LTD | 5,221.47 | 17.64 | 92,098.8 |
| ZYDUS LIFESCIENCES LTD | 4,159.00 | 28.91 | 120,249.0 |
| AUROBINDO PHARMA LTD | 3,993.05 | 26.01 | 103,856.0 |
| LAURUS LABS LTD | 1,333.75 | 97.03 | 129,410.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs HESTER BIOSCIENCES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 14.57x |
| Max industry PE | 97.03x |
| Median industry PE | 41.02x |
| Average industry PE | 48.28x |
You may also like the below Video Courses